Neuberger Berman Group LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$208,000
-1.4%
8,0850.0%0.00%
Q2 2021$211,000
-63.2%
8,085
-50.2%
0.00%
-100.0%
Q1 2021$574,000
+33.2%
16,246
-3.3%
0.00%
Q4 2020$431,000
-29.7%
16,801
+5.6%
0.00%
-100.0%
Q3 2020$613,000
+0.5%
15,910
+11.6%
0.00%0.0%
Q2 2020$610,000
+130.2%
14,260
+4.9%
0.00%
Q1 2020$265,00013,6000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders